SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : son of T/FIF -- Ignore unavailable to you. Want to Upgrade?


To: gue who wrote (177)9/18/1999 12:18:00 AM
From: Jim Oravetz  Respond to of 673
 
Hey, John Schoen:
<....Picking biotech stocks can be tricky; analysts note that many
smaller companies can be one-product wonders. Less risky
are the larger companies that have multiple products on the
market and many more in the pipeline. J.P. Morgan's
Berger likes Genentech, Amgen and Biogen....>

ZZZZZZZZZZZZZZZZZZz!

But the biggest gains can come from the smallest companies.

There ya go!

++++ FYI +++++++
Research and Commercial Genomics Meet
(Human Genome Project + Celera Genomics)
usnews.com

Celera on NPR (Realplayer req'd)
search.npr.org

Jim